CJC-1295 + Ipamorelin and BPC-157 Together: What Is Known
CJC-1295 + Ipamorelin and BPC-157 taken together: what each one is, how each is regulated, and what is known about combining them.
Timing, interactions and safety
Evidence for the combination
No studies tested these together (PubMed search: 7 results, 2 Oct 2026).
Side by side
Showing 12 of 12 fields where the two differ.
| Field | CJC-1295 + Ipamorelin | BPC-157 |
|---|---|---|
| Class | GHRH + GHRP blend | Gastric pentadecapeptide |
| Also called | CJC/Ipa | BPC, body protection compound, Pentadecapeptide BPC 157 |
| Category | Growth hormone | Healing & recovery |
| FDA status | Not FDA approved · research blend | PCAC voted 8–6 for 503A (Jul 2026) |
| PCAC vote, Jul 2026 | Not on the Jul 2026 agenda | PCAC voted 8–6 for the 503A list (Jul 2026); not finalized |
| WADA | Prohibited by WADA (S2.2.4)Both components are named in S2.2.4 (CJC-1295 as a GHRH analogue, ipamorelin as a secretagogue), so the blend is prohibited at all times. | Prohibited by WADA (S0)BPC-157 is named in S0 (non-approved substances), prohibited at all times, in and out of competition. |
| Anti-doping detection |
|
|
| Half-life | Ipamorelin: 2 hours terminal half-lifeintravenous infusion (15 min) · Pharmaceutical research 1999, PMID 10496658 | less than 30 minIV and IM (single and repeated) (rat, beagle dog) · Frontiers in pharmacology 2022, PMID 36588717 |
| Evidence strength | Human RCT evidence, 4 of 4Ipamorelin: International journal of colorectal disease 2014, PMID 25331030 | Human observational evidence, 3 of 4Strongest: Alternative therapies in health and medicine 2025, PMID 40131143 |
| Human studies we summarised | 6 human (3 randomized or controlled) of 19 summarised, across ingredients | 3 human (0 randomized or controlled) of 25 summarised |
| Typical study doses |
|
|
| Vial sizes sold | 10 mg | 2 mg, 5 mg, 10 mg, 20 mg |
The blend and its status
A Drugs@FDA lookup for the CJC-1295/ipamorelin blend returned no match.[14]
After multiple CJC-1295 doses in the cited trial, mean IGF-I levels stayed above baseline for up to 28 d.[6]
BPC-157 evidence
In transected rat Achilles tendon, BPC 157 improved biomechanical and functional recovery; this is rat data.[16]
The sports-medicine review of BPC-157 states that no clinical safety data were found.[17]
CJC-1295 safety record
In the CJC-1295 dose-escalation trials, no serious adverse reactions were reported.[6]
Which CJC-1295 do the human data cover?
A review of performance peptides lists CJC-1295 with a Drug Affinity Complex (DAC) and CJC-1295 without DAC as separate agents.[18]
Tested together?
The search for the blend with BPC-157 returned 7 PubMed records, none classed as a study of the combination.
Calculated from pubmed query ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (("CJC-1295"[tiab] OR CJC1295[tiab]) AND (ipamorelin[tiab])); search date 2026-10-02; records returned 7; records classed as study of the pair 0. Formula: Counts copied from the combinations dataset (web/src/data/combinations.json, key bpc-157__cjc-1295-ipamorelin); no arithmetic applied.
Common questions
Can you stack CJC-1295/ipamorelin with BPC-157?
No study tested that three-peptide combination; the sources only cover the pieces separately.[6]
Sources
- 1FDA gives notice that 12 peptides will be removed from Category 2 (nominations withdrawn)FDA · 2026fda.govAccessed 2 Oct 2026
- 2World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 3Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin.Drug testing and analysis · 2015PMID 25869809Accessed 2 Oct 2026
- 4Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.Pharmaceutical research · 1999PMID 10496658Accessed 2 Oct 2026
- 5Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.International journal of colorectal disease · 2014PMID 25331030Accessed 2 Oct 2026
- 6Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.The Journal of clinical endocrinology and metabolism · 2006PMID 16352683Accessed 2 Oct 2026
- 7Stable Isotope Labeling-Based Nontargeted Strategy for Characterization of the In Vitro Metabolic Profile of a Novel Doping BPC-157 in Doping Control by UHPLC-HRMS.Molecules (Basel, Switzerland) · 2023PMID 37959764Accessed 2 Oct 2026
- 8Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H.Drug testing and analysis · 2017PMID 28035768Accessed 2 Oct 2026
- 9Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs.Frontiers in pharmacology · 2022PMID 36588717Accessed 2 Oct 2026
- 10Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study.Alternative therapies in health and medicine · 2025PMID 40131143Accessed 2 Oct 2026
- 11Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study.Alternative therapies in health and medicine · 2024PMID 39325560Accessed 2 Oct 2026
- 12Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.Joint diseases and related surgery · 2026PMID 42542926Accessed 2 Oct 2026
- 13PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (("CJC-1295"[tiab] OR CJC1295[tiab]) AND (ipamorelin[tiab]))PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 14Drugs@FDA (openFDA) search: active ingredient "CJC-1295"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
- 15Advisory committee backs 6 of 7 peptides for the 503A listNCPA · 2026ncpa.org
- 16Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2003PMID 14554208Accessed 2 Oct 2026
- 17Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2025PMID 40756949Accessed 2 Oct 2026
- 18The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.Frontiers in endocrinology · 2026PMID 42395176Accessed 2 Oct 2026
Found an error? Report a correction.